The June 15 edition of the Journal of the American Veterinary Medical Association warns of restrictions imposed by the FDA on the extra-label use of drugs by veterinarians.
According to the Animal Medicinal Drug Use Clarification Act, veterinarians are afforded flexibility in administering drugs to help relieve animal pain and suffering. Financial considerations in using a drug registered for a given species or an alternative species is unacceptable.
Some latitude is allowed with respect to using human drugs for companion animals. Deviation from AMDUCA is associated with risks of sanctions by the FDA, which may extend from a warning letter to desist through to prosecution.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment